Dajas Federico, Rivera Felicia, Blasina Fernanda, Arredondo Florencia, Echeverry Carolina, Lafon Laura, Morquio Andrea, Heinzen Horacio
Department of Neurochemistry, Instituto de Investigaciones Biológicas Clemente Estable, Avda Italia 3318, 11600 Montevideo, Uruguay.
Neurotox Res. 2003;5(6):425-32. doi: 10.1007/BF03033172.
Flavonoids are an important group of recognized antioxidants ubiquitous in fruits, vegetables and herbs. There are epidemiological evidences for the stroke-protecting capacity of flavonoids and while the neuroprotective power of complex extracts rich in flavonoids like those of Ginkgo biloba, green tea or lyophilized red wine have been demonstrated in several studies, neuroprotection by individual flavonoids has been poorly studied in vivo. The neuroprotective capacity of individual flavonoids was studied in PC12 cells in culture and in a model of permanent focal ischemia (permanent Middle Cerebral Artery Occlusion - pMCAO). In the in vivo experiments, flavonoids were administered in lecithin preparations to facilitate the crossing of the blood brain barrier. The simultaneous incubation of PC12 cells with 200 micro M hydrogen peroxide (H2O2) and different flavonoids for 30 min resulted in a conspicuous profile: quercetin, fisetin, luteolin and myricetin significantly increased cell survival while catechin, kaempherol and taxifolin did not. Quercetin was detected in brain tissue 30 min and 1 h after intraperitoneal administration. When one of the protective flavonoids (quercetin) and one of those that failed to increase PC12 cell survival (catechin) were assessed for their protective capacity in the pMCAO model, administered i.p. 30 min after vessel occlusion, quercetin significantly decreased the brain ischemic lesion while catechin did not. It is concluded that when administered in liposomal preparations, flavonoids structurally related to quercetin could become leads for the development of a new generation of molecules to be clinically effective in human brain ischemia.
黄酮类化合物是一类重要的公认抗氧化剂,广泛存在于水果、蔬菜和草药中。有流行病学证据表明黄酮类化合物具有预防中风的能力,虽然在多项研究中已证实富含黄酮类化合物的复合提取物(如银杏叶、绿茶或冻干红酒中的提取物)具有神经保护作用,但对单个黄酮类化合物的体内神经保护作用研究较少。在培养的PC12细胞和永久性局灶性缺血模型(永久性大脑中动脉闭塞 - pMCAO)中研究了单个黄酮类化合物的神经保护能力。在体内实验中,黄酮类化合物以卵磷脂制剂形式给药,以促进其穿过血脑屏障。将PC12细胞与200微摩尔过氧化氢(H2O2)和不同黄酮类化合物同时孵育30分钟,结果呈现出明显差异:槲皮素、漆黄素、木犀草素和杨梅素显著提高细胞存活率,而儿茶素、山奈酚和紫杉叶素则不然。腹腔注射后30分钟和1小时在脑组织中检测到槲皮素。当在pMCAO模型中评估一种具有保护作用的黄酮类化合物(槲皮素)和一种未能提高PC12细胞存活率的黄酮类化合物(儿茶素)的保护能力时,在血管闭塞后30分钟腹腔注射,槲皮素显著减少脑缺血损伤,而儿茶素则没有。得出的结论是,当以脂质体制剂给药时,与槲皮素结构相关的黄酮类化合物可能成为开发新一代对人脑缺血具有临床疗效的分子的先导物。